Table 4 Analysis of factors influencing early recurrence in the ineffective ibutilide group
Early recurrence(n = 13) | Early non-recurrence(n = 64) | P | |
|---|---|---|---|
Age (years old) | 65.31 ± 10.07 | 60.44 ± 11.93 | 0.149 |
Weight(kg) | 69.77 ± 9.36 | 73.46 ± 12.54 | 0.319 |
Duration of atrial fibrillation (months) | 91.92 ± 100.43 | 61.37 ± 94.10 | 0.048* |
Male | 9(69.2%) | 52(81.2%) | 0.549 |
Female | 4(30.8%) | 12(18.8%) | |
Heart failure | 3(23.1%) | 7(10.9%) | 0.463 |
Hypertension | 7(53.8%) | 30(46.9%) | 0.646 |
Diabetes | 3(23.1%) | 9(14.1%) | 0.691 |
Coronary heart disease | 3(23.1%) | 8(12.5%) | 0.576 |
Stroke history | 2(15.4%) | 7(10.9%) | 1.000 |
Peripheral vascular disease | 4(30.8%) | 15(23.4%) | 0.837 |
CHA2DS2-VASc score | 2.85 ± 1.77 | 2.01 ± 1.67 | 0.091 |
LA diameter(mm) | 48.17 ± 5.86 | 47.21 ± 6.19 | 0.587 |
EF(%) | 61.62 ± 9.90 | 61.10 ± 9.17 | 0.872 |
NT-proBNP(pg/mL) | 683.08 ± 474.12 | 658.78 ± 694.04 | 0.550 |